Skip to main content

Table 11 Use of urine β-subunit core fragment as a tumor marker for detection of malignancies.

From: New discoveries on the biology and detection of human chorionic gonadotropin

Malignancy

Patients

Sensitivity (> 3 fmol/ml)

Healthy no history of malignancy

97

9.3%

Healthy benign disease

159

6.9%

TOTAL

256

7.8%

Ovarian cancer

106

68%

Cervical cancer

89

46%

Endometrial cancer

110

51%

Pancreatic cancer

29

55%

Bladder cancer

102

48%

Lung cancer

122

24%

TOTAL

558

47%